Recursion Pharmaceuticals Inc Cl A (RXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 264,126 | 0 | 0 | 0 | 75,171 |
| Receivables | 156 | 0 | 0 | 0 | 151 |
| Other current assets | 2,155 | 0 | 0 | 0 | 1,076 |
| TOTAL | $266,437 | $0 | $0 | $0 | $76,398 |
| Non-Current Assets | |||||
| PPE Net | 25,967 | N/A | N/A | N/A | 30,085 |
| Intangibles | 2,490 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 3,691 | 0 | 0 | 0 | 663 |
| TOTAL | $32,148 | $N/A | $N/A | $N/A | $30,748 |
| Total Assets | $298,585 | $0 | $0 | $0 | $101,431 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,074 | 0 | 0 | 0 | 1,261 |
| Accrued Expenses | 10,485 | 0 | 0 | 0 | 4,879 |
| Other current liabilities | 10,000 | 0 | 0 | 0 | 0 |
| TOTAL | $23,099 | $0 | $0 | $0 | $6,684 |
| Non-Current Liabilities | |||||
| Long Term Debt | 11,414 | 0 | 0 | 0 | 12,418 |
| Other Non-Current Liabilities | 19,375 | 0 | 0 | 0 | 0 |
| TOTAL | $33,463 | $N/A | $N/A | $N/A | $14,696 |
| Total Liabilities | $56,562 | $0 | $0 | $0 | $24,587 |
| Shareholders' Equity | |||||
| Retained earnings | -213,601 | 0 | 0 | 0 | -126,595 |
| Other shareholders' equity | 448,312 | 0 | 0 | 0 | 201,109 |
| TOTAL | $242,023 | $0 | $0 | $0 | $76,844 |
| Total Liabilities And Equity | $298,585 | $0 | $0 | $0 | $101,431 |